Q1 2024 · 13F-HR
Bill & Melinda Gates Foundationholdings as filed
Filed 2024-05-14 · accession 0000898432-24-000405
$84.1M
Reported value
8
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 45258D105 | IMCR | IMMUNCORE HLDGS PLC | $37.5M | 44.6% | 576,923 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $15.8M | 18.8% | 1,559,142 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $13.7M | 16.3% | 148,674 | Common | SOLE |
| 30223G102 | EXAIEUR | EXSCIENTIA | $9.1M | 10.8% | 1,590,909 | Common | SOLE |
| N2451R105 | CVAC | CUREVAC N V | $6.7M | 7.98% | 1,597,637 | Common | SOLE |
| 124155102 | BFLY | BUTTERFLY NETWORK INC | $1.1M | 1.30% | 1,011,003 | Common | SOLE |
| G5709L109 | — | LUMIRADX LTD | $142,857 | 0.17% | 14,285,714 | Common | SOLE |
| 04965G109 | BCELUSD | ATRECA INC | $73,011 | 0.09% | 912,642 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.